Formulation
Tesamorelin
THECARE / PRODUCT PROTOCOL
Single ingredientTesamorelin20 mg
Your guide to preparation, dosing & use.
Vial strength20 mg per vial
After preparation20 mg / 2 mL
AdministrationSubcutaneous (SQ)
01
PRODUCT INFORMATION
Benefits
Who it is intended for
Confirm your treatment goal with your care team before starting.
02
WHAT TO WATCH FOR
Side Effects
Review the side effects for your exact product with your care team and read its label before your first dose.
When to pause and get help
Pause use and get help for red flag symptoms, unexpected side effects, dose errors, missed doses with symptoms, pregnancy, new diagnosis, new medication, or uncertainty about storage/reconstitution.
03
WHEN TO GET HELP
Adverse Effects
URGENT SYMPTOMS
Get urgent medical help.
Severe allergic reaction, trouble breathing, chest pain, fainting, severe abdominal pain, persistent vomiting, severe swelling, infection signs, or rapidly worsening symptoms require urgent medical help.
Who needs a safety review?
Before using this product
Pregnant/breastfeeding clients, minors, clients with active infection, uncontrolled medical conditions, severe allergies, or complex medication histories should complete safety review before use. Cancer history, endocrine disorders, uncontrolled diabetes, edema, or growth-hormone-axis concerns should complete safety review before use.
Conditions and medicines to review
Pregnant/breastfeeding clients, minors, clients with active infection, uncontrolled medical conditions, severe allergies, or complex medication histories should complete safety review before use. Cancer history, endocrine disorders, uncontrolled diabetes, edema, or growth-hormone-axis concerns should complete safety review before use. Disclose all prescriptions, OTC medications, supplements, allergies, and prior reactions.
04
MEASURE CORRECTLY
Dosing Guide
YOUR DOSE · FOLLOW YOUR PRESCRIPTION
10 units (0.10 mL = 1 mg) SQ nightly before bed, for 5 days followed by 2 days off.
Units refer to U-100 syringe markings.
Doses per vial
20 doses of 10 units per vial; 4 weeks at 5 doses per week. Follow the discard date on your vial.
Dose changes
Change your dose only when your care team gives you the new amount and start date.
U-100 syringe conversion
For Tesamorelin 20 mg in 2 mL after preparation.
| Syringe mark U-100 | Volume mL | Tesamorelin mg |
|---|---|---|
| 1 | 0.01 | 0.1 |
| 5 | 0.05 | 0.5 |
| 10 | 0.10 | 1 |
| 20 | 0.20 | 2 |
| 25 | 0.25 | 2.5 |
| 50 | 0.50 | 5 |
1 U-100 marking = 0.01 mL. Multiply the amount per vial by the mL drawn, then divide by the final mL in the vial. Amounts are rounded for display; match the vial label and written order.
Preparation & storage
Mixing instructions
Mix with 2 mL of the diluent specified on your product label. Confirm the diluent type with your care team before mixing.
Package contents
Tesamorelin 20 mg vial.
Supplies
Confirm the correct diluent, syringe, needles, alcohol pads, and sharps container are available before starting.
Before mixing / opening
Store at the temperature on your product label. Protect from light and follow the expiry date.
After mixing
Write the mixing date on your vial. Follow its storage temperature and discard date. Discard any remaining solution on that date.
If the package arrives warm
Do not use if package integrity is questionable. Contact support for review and keep product per storage instructions while awaiting guidance.
05
USE & FOLLOW-UP
Protocol
Route
SQ / subcutaneous (into fat).
Injection site
Subcutaneous fat; follow the prescribed site and training.
Subcutaneous injection: choose a site
Abdomen
Choose fatty tissue at least 2 inches (5 cm) from the navel.
Side of abdomen
Choose healthy fatty tissue below the ribs and above the hip bone.
Back of upper arm
A trained helper can use the fatty tissue on the back of the upper arm.
Outer thigh
Choose fatty tissue on the outer middle thigh, away from the knee and hip.
45° and 90° examples
These illustrations identify tissue layers and example angles; they are not to scale. Needle length, angle and whether to lift a fold depend on the prescribed device and your training; stop and ask the clinic if either is unspecified.
Check the order and equipment
Match name, vial strength, final concentration, SQ route, expiration and discard date to your prescription. Use the prescribed U-100 syringe only if the order specifies it; its marks measure volume.
Prepare and measure
Wash and dry hands. Use a clean surface, a new sterile needle and syringe, and an alcohol pad. Check solution appearance, clean the stopper and let it dry. Draw only the prescribed volume and recheck the mark and bubbles.
Choose and clean a site
Choose one healthy site shown above and rotate each time. Avoid red, hard, bruised, scarred or tender skin. Clean the spot and let it dry. Do not touch it again.
Inject into fatty tissue
Gently lift a skin-and-fat fold if your training calls for it. Use the 45° or 90° angle specified for your needle and body habitus. Insert into fat, press the plunger steadily, then withdraw at the same angle.
Finish and dispose
Press clean gauze if needed; do not rub. Do not recap or reuse the needle. Put needle and syringe immediately in a sharps container; close it at about three-quarters full and use local disposal rules.
Missed dose or error
Do not double, repeat, or titrate without the written order. Contact the clinic for a discrepancy, uncertain storage, or unexpected reaction; urgent symptoms need emergency care.
Refills and switching
When to reorder
Reorder before the earlier of measured supply and the dispensing label's discard date; confirm the active course and dose.
Before a refill
Current dose, frequency, response, side effects, weight/goal changes if relevant, missed doses, remaining supply, and any new medications or medical changes.
Before switching
Previous product name, dose, last injection date, side effects, response, reason for switching, current medications, and confirmation that switching is appropriate.